Takara Financial Statements From 2010 to 2026

Stocks . Germany . 
Stock . Takara Bio
TF2 Stock  EUR 5.85  0.85  17.00%   
Takara Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Takara Bio's valuation are provided below:
Gross Profit
23.8 B
Profit Margin
(0.16)
Market Capitalization
761.3 M
Enterprise Value Revenue
2.3751
Revenue
44.1 B
There are over seventy-four available fundamental trend indicators for Takara Bio, which can be analyzed over time and compared to other ratios. Active traders should verify all of Takara Bio current fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road.

Takara Bio Total Revenue

45.12 Billion

Check Takara Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Takara Bio's main balance sheet or income statement drivers, such as Interest Expense of 24.1 M, Selling General Administrative of 601.1 M or Total Revenue of 45.1 B, as well as many indicators such as . Takara financial statements analysis is a perfect complement when working with Takara Bio Valuation or Volatility modules.
  
This module can also supplement various Takara Bio Technical models . Check out the analysis of Takara Bio Correlation against competitors.

Takara Bio Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets97.1 B144.1 B87.5 B
Slightly volatile
Other Current Liabilities2.5 B2.6 B4.4 B
Slightly volatile
Total Current Liabilities9 B8.2 B7.6 B
Slightly volatile
Total Stockholder Equity86 B132.8 B78.1 B
Slightly volatile
Other Liabilities1.2 B1.6 B1.1 B
Slightly volatile
Net Tangible Assets69.9 B118.6 B70.3 B
Slightly volatile
Retained Earnings63.4 B60.3 B27.2 B
Slightly volatile
Accounts Payable1.9 B1.9 B1.7 B
Slightly volatile
Cash25.7 B34 B21.1 B
Slightly volatile
Other Assets729.8 M963 M1.1 B
Slightly volatile
Long Term Debt123.8 M73.8 M126.9 M
Slightly volatile
Net Receivables10.8 B15.2 B9.6 B
Slightly volatile
Good Will5.6 B7.5 B4.6 B
Slightly volatile
Short Term Investments1.7 B1.8 B8.4 B
Slightly volatile
Inventory10 B14.3 B8.6 B
Slightly volatile
Other Current Assets2 B2.8 B1.7 B
Slightly volatile
Total Liabilities10.9 B10.9 B9.2 B
Slightly volatile
Long Term Investments1.2 B803.7 M984.9 M
Very volatile
Short and Long Term Debt40.2 M42.3 M129.6 M
Slightly volatile
Total Current Assets53.9 B66.3 B49.1 B
Slightly volatile
Short Term Debt40.2 M42.3 M129.6 M
Slightly volatile
Intangible Assets2.8 B1.7 B2.1 B
Slightly volatile
Common Stock12 B13.5 B14.7 B
Slightly volatile
Property Plant Equipment27.4 B47.1 B26.8 B
Slightly volatile
Non Current Assets Total48.3 B77.8 B38.9 B
Slightly volatile
Non Currrent Assets Other1.8 B1.7 B564.5 M
Slightly volatile
Common Stock Shares Outstanding96.3 M108.4 M118.3 M
Slightly volatile
Non Current Liabilities Total2.1 B2.7 B1.7 B
Slightly volatile
Non Current Liabilities Other400.2 M529 M324.5 M
Slightly volatile
Net Invested Capital96.5 B132.8 B80.2 B
Slightly volatile
Net Working Capital47.7 B58.1 B38.7 B
Slightly volatile
Capital Stock12 B13.5 B14.7 B
Slightly volatile
Property Plant And Equipment Net43.5 B65.5 B33.2 B
Slightly volatile
Capital Lease Obligations846.5 M990.9 M1.1 B
Slightly volatile
Property Plant And Equipment Gross63.8 B94.6 B50.2 B
Slightly volatile

Takara Bio Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative601.1 M632.7 M3.3 B
Slightly volatile
Total Revenue45.1 B51.8 B38.9 B
Slightly volatile
Gross Profit27.4 B30 B23.2 B
Slightly volatile
Operating Income2.5 B2.6 B6.2 B
Slightly volatile
Net Income From Continuing Ops1.2 B1.3 B4.1 B
Slightly volatile
EBIT24.8 B23.6 B10.9 B
Slightly volatile
Research Development5.8 B7.9 B5.1 B
Slightly volatile
Cost Of Revenue17.7 B21.8 B15.7 B
Slightly volatile
Total Operating Expenses36.5 B49.2 B32.3 B
Slightly volatile
Income Before Tax2.2 B2.3 B6 B
Slightly volatile
Net Income Applicable To Common Shares24 B22.8 B9.1 B
Slightly volatile
Net Income1.1 B1.2 B4.1 B
Slightly volatile
Income Tax Expense6.3 B6 B3 B
Slightly volatile
Tax Provision994.2 M1 B2.1 B
Pretty Stable
Net Interest Income338.1 M322 M143.1 M
Slightly volatile
Interest Income362.2 M345 M154.9 M
Slightly volatile
EBITDA18.2 B29.9 B14.5 B
Slightly volatile
Reconciled Depreciation4.4 B5.2 B3.8 B
Slightly volatile

Takara Bio Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock9.2 B10.3 B11.3 B
Slightly volatile
Depreciation3.6 B5.2 B3 B
Slightly volatile
Capital Expenditures6.9 B11.8 B6.6 B
Slightly volatile
Total Cash From Operating Activities8.6 B6.7 B6.8 B
Slightly volatile
Net Income1.1 B1.2 B4 B
Slightly volatile
End Period Cash Flow23.8 B31.1 B17.6 B
Slightly volatile
Begin Period Cash Flow23.2 B38.1 B16.7 B
Slightly volatile

About Takara Bio Financial Statements

Takara Bio stakeholders use historical fundamental indicators, such as Takara Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Takara Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Takara Bio's assets and liabilities are reflected in the revenues and expenses on Takara Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Takara Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue51.8 B45.1 B
Cost Of Revenue21.8 B17.7 B

Currently Active Assets on Macroaxis

FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
CSANCosan SA ADR
RKTRocket Companies

Other Information on Investing in Takara Stock

Takara Bio financial ratios help investors to determine whether Takara Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Takara with respect to the benefits of owning Takara Bio security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY